ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification.

Usanarat Anurathapan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.